Anti-Adrenomedullin-Antikörper (ADM) oder Anti-ADM-Antikörperfragment oder non-Ig Anti-ADM-Proteingerüst zur Reduzierung des Sterblichkeitsrisikos bei einem Patienten mit chronischer oder akuter Erkrankung oder in einem akuten Zustand
European patent · EP2594587 · In force
Register entry
- Publication number
- EP2594587
- Application number
- EP12193118
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 16, 2012
- Published
- May 22, 2013
- Granted
- May 21, 2014
- Protection ends at the latest
- Nov 15, 2032
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07K 16/26 (2006.01)A61K 39/395 (2006.01)A61P 31/00 (2006.01)A61P 9/00 (2006.01)A61P 13/12 (2006.01)
- Priority
- EP 11189450 16.11.2011EP 12160017 16.03.2012
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Dec 1, 2022
Change
Published in Swissreg on 01.12.2022
- Sep 22, 2021
Transferred
- Owner
- AdrenoMed AG, Neuendorfstrasse 19a, 16761 Hennigsdorf, Germany → AdrenoMed AG, Neuendorfstrasse 15a, 16761 Hennigsdorf, Germany
Published in Swissreg on 22.09.2021
- Nov 22, 2014
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 22.11.2014
- May 21, 2014
Granted
Published in Swissreg on 21.05.2014
Parties
Inventor
Bergmann, Andreas
13465 Berlin, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.